PRISM Stock IndexesCurrent Value% Change (Daily)% Change (Inception)Most ActiveTop % GainersTop % Losers
Cannabis$68.101.2%-31.9%TLRY 12,250CLVR 6.728%TCNNF -5.147%
EV$44.801.3%-55.2%IDEX 70,036HYLN 8.917%CHPT -6.974%
Gene Therapy$56.800.8%-43.2%BLUE 4,789WVE 9.375%BLCM -25%
MedDevices$181.901.3%81.9%MBOT 3,578RCEL 10.064%MBOT -18.519%
MedDiagnostics$88.502%-11.5%TTOO 7,739QLGN 9.363%BSGM -7.692%
NextGen Tech$81.90-1.9%-18.1%AI 25,864NOTE 10.092%IONQ -13.993%
Solar$73.602.3%-26.4%SIRC 9,283SOL 9.402%CSIQ -2.297%
Uranium$90.8018.9%-9.2%UEC 6,288EGRAF 494.059%BSENF -6.151%
Vaccines & Cell Therapy$161.201.1%61.2%SRNE 36,504RCEL 10.064%PDSB -4.849%
Zombie$206.702.8%106.7%SNAP 29,318BW 12.298%APRN -2.734%

North Korea denounces UN over satellite, ‘gangster-like’ US demand

SEOUL (Reuters) -North Korea denounced on Sunday the U.N. Security Council for discussing its recent satellite launch in response to a “gangster-like U.S. request”, and… [Read More]

Prism View

Asensus Shares First Quarter Results and Future Plans

NEW YORK, NY - (NewMediaWire) - June 1, 2023 - PCG Digital --Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery(TM), recently…

BIT Mining to Collaborate with Chain Reaction for Bitcoin Hashing Systems

Cryptocurrency mining company, BIT Mining (NYSE: BTCM) will collaborate with Chain Reaction to produce next-generation systems for bitcoin mining. The new-generation hardware will deliver industry leading performance with relatively low power consumption and is expected to launch in the second…

Color Star Technology to Host Color Cup WBA World Boxing Championship

Entertainment technology company Color Star Technology (Nasdaq: ADD) has entered into an official partnership with The World Boxing Association (WBA) to host the Color Cup WBA World Boxing Championship in multiple regions and countries worldwide. The event will mark Color…

OpenLocker (OLKR) Tunes Up Its Fan Engagement Focus with Launch of Podcast, OpenLocker Network

Publicly traded OpenLocker Holdings, Inc. (OLKR) has announced the launch of its new podcast, Open Locker…

BrainChip and CVEDIA to Advance Edge AI and Neuromorphic Computing

Neuromorphic AI IP producer, BrainChip Holdings (OTCQX: BRCHF), will partner with CVEDIA, a leading provider of…

FiscalNote Enters Collaboration with Microsoft

AI-driven enterprise SaaS technology provider, FiscalNote (NYSE: NOTE), has entered a collaboration with Microsoft to build…

TuSimple Announces Restructure of US Operations

Global autonomous driving technology company, TuSimple (Nasdaq: TSP), has announced a restructuring plan for its US…

Feature Story

Four Next-Gen Sectors to Watch

Next-Gen stocks – companies in innovative growth sectors including biotechnology, renewable energy, AI, blockchain technology, electric vehicles (EV), and others – are attracting the attention of investors with their potential for long term gains.

The original Next-Gen stocks, Facebook (Nasdaq: META), Amazon (Nasdaq: AMZN), Netflix (Nasdaq: NFLX) and Google (Nasdaq: GOOG), famous for their impressive growth, lack of volatility and superior rates of return, have dominated investor buying demand.

(more…)

Bio View

FDA Accepts Iovance’s Biologics License Application for Melanoma Treatment

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) has announced that the FDA has accepted its Biologics License Application (BLA) for lifileucel for patients with advanced melanoma. The FDA granted lifileucel Priority Review and assigned November 25, 2023 as the target action date…

BioXcel Therapeutics Announces Promising Topline Results from Clinical Trial for Bipolar Disorders or Schizophrenia Treatment

BioXcel Therapeutics (Nasdaq: BTAI) has announced promising results from a Phase 3 clinical trial of BXCL501, its proprietary, orally dissolving film of dexmedetomidine as a treatment for agitation in bipolar disorders or schizophrenia. BXCL501 was well tolerated and demonstrated favorable…

Verastem Oncology Reports Clinically Meaningful Response Rates in Phase 2 Study in Ovarian Cancer

Verastem Oncology (Nasdaq: VSTM) has reported clinically meaningful response rates in a Phase 2 trial evaluating the safety and efficacy of avutometinib (VS-6766) alone and in combination with defactinib among patients with recurrent low-grade serous ovarian cancer (LGSOC). There are…

Hepion Pharmaceuticals’ Phase 2 Clinical Trial Meets Primary and Secondary Endpoints

Hepion Pharmaceuticals (Nasdaq: HEPA) has announced positive topline results from its recently completed Phase 2 ALTITUDE-NASH…

Quoin Reaches 50% Enrollment in Netherton Syndrome Trial

Company anticipates releasing topline data later this year Clinical-stage specialty pharmaceutical company Quoin Pharmaceuticals Ltd. (NASDAQ…

Wave Life Sciences: No Clinical Benefit Observed in Phase 1b/2a Trial for ALS and Frontotemporal Dementia Treatment

Clinical stage RNA medicines company, Wave Life Sciences (Nasdaq: WVE) has failed to meet primary endpoints…

SS Innovations International, Inc. Commences Trading on OTC under symbol SSII; Provides Corporate Update

SS Innovations International, Inc. (OTC: SSII), a developer of innovative, affordable and accessible surgical robotic technologies,…

Traders Lens

Mastercard ($MA)

$MA has been finding strong resistance at $390 on its weekly chart. Breaking above $390 but not being able to close above it a few times in the last couple of years. A close above could lead to a nice bullish continuation.

Prism Daily

Stocks making the biggest moves premarket: SentinelOne, Lululemon, Dupont and more

A view of a Canadian athletic apparel retailer Lululemon logo seen at one of their stores. Alex Tai | LightRocket | Getty Images Check out the companies making headlines in early morning trading. MongoDB — The data developer platform stock surged 27% after the company issued a strong forecast for the second quarter, seeing between $388… [Read More]

Top Gainers and Losers from the Investors Prism Index.

$CVNA was the biggest winner of the entire group and $EGRAF was the largest detractor. [Read More]

Stocks making the biggest moves midday: Dollar General, Salesforce, C3.ai, Chewy and more

A sign is posted in front of a Dollar General store in Vallejo, California, March 17, 2022. Justin Sullivan | Getty Images Check out the companies making the biggest moves midday. Dollar General — Shares sank nearly 20% after the company reported an earnings and revenue miss for the first quarter. The company also slashed its full-year… [Read More]